1,2,3,4,6-Penta-O-galloyl-beta-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor

Cancer Letters

Volumn 208, Issue 1, 2004, Pages 89-94

  Lee, Sung Jin ^a   Lee, Hwan Myung ^b   Ji, Seung Taek ^c   Lee, Seung Rock ^d   Mar, Woongchon ^a   Gho, Yong Song ^b  

^a Seoul National University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Bioinfomatix Inc   (South Korea)

^d Ewha Womans University   (South Korea)

Author keywords

1,2,3,4,6 Penta O galloyl beta D glucose; Angiogenesis; Cancer; KDR Flk 1; Vascular endothelial growth factor

Indexed keywords

1,2,3,4,6 PENTA O GALLOYL BETA DEXTRO GLUCOSE; ANGIOGENESIS INHIBITOR; GLUCOSE DERIVATIVE; PAEONIA EXTRACT; PAEONIA LACTIFLORA EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CAPILLARY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROSARCOMA; HUMAN; HUMAN CELL; IMMOBILIZED CELL; INHIBITION KINETICS; MEDICINAL PLANT; PAEONIA LACTIFLORA; PLANT ROOT; PRIORITY JOURNAL; PROSTATE CARCINOMA; RECEPTOR BINDING; TUMOR VASCULARIZATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELL DIVISION; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FIBROSARCOMA; HUMANS; HYDROLYZABLE TANNINS; LAMININ; MALE; NA(+)-K(+)-EXCHANGING ATPASE; PAEONIA; PLANT EXTRACTS; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEOGLYCANS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TANNINS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

PAEONIA; PAEONIA LACTIFLORA;

EID: 16544364669     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.11.008     Document Type: Article

References (27)

1. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407:2000;249-257.
2. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9:2003;653-660.
3. Zetter B.R. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49:1998;407-424.
4. Boehm-Viswanathan T. Is angiogenesis inhibition the Holy Grail of cancer therapy? Curr. Opin. Oncol. 12:2000;89-94.
5. Gospodarowicz D., Abraham J.A., Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl Acad. Sci. USA. 86:1989;7311-7315.
6. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Frrarara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
7. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:1993;835-846.
8. De Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989-991.
9. Shalaby F., Rossant J., Yamaguch T., Gertsenstein M., Wu X.F., Breitman M.L., Schuh S.C. Failure of blood-island formation vasculogenesis in Flk-1-deficient mice. Nature. 376:1995;62-66.
10. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
11. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
12. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 362:1993;841-844.
13. Millauer B., Shawver L.K., Plate K.H., Risau W., Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature. 367:1994;576-579.
14. Goldman C.K., Kendall R.I., Cabrera G., Soroceanu L., Heike Y., Gillespie G.Y., et al. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl Acad. Sci. USA. 95:1998;8795-8800.
15. Kim Y.M., Hwang S., Kim Y.M., Pyun B.J., Kim T.Y., Lee S.T., et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem. 277:2002;27872-27879.
16. Bae D.G., Gho Y.S., Yoon W.H., Chae C.B. Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis. J. Biol. Chem. 275:2000;13588-13596.
17. Lamy S., Gingras D., Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res. 62:2002;381-385.
18. Kondo T., Ohta T., Igura K., Hara Y., Kaji K. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett. 180:2002;139-144.
19. Martiny-Baron G., Marme D. VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Curr. Opin. Biotechnol. 6:1995;675-680.
20. Veikkola T., Alitalo K. VEGFs, receptors and angiogenesis, Semin. Cancer Biol. 9:1999;211-220.
21. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer. 2:2002;795-803.
22. Kim C.W., Lee H.M., Lee T.H., Kang C., Kleinman H.K., Gho Y.S. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. 62:2002;6312-6317.
23. Oh G.S., Pae H.O., Oh H., Hong S.G., Kim I.K., Chai K.Y., et al. In vitro anti-proliferative effect of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose on human hepatocellular carcinoma cell line, SK-HEP-1 cells. Cancer Lett. 174:2001;17-24.
24. Wroblewski K., Muhandiram R., Chakrabartty A., Bennick A. The molecular interaction of human salivary histatins with polyphenolic compounds. Eur. J. Biochem. 268:2001;4384-4397.
25. Miyamoto K., Kishi N., Koshiura R., Yoshida T., Hatano T., Okuda T. Relationship between the structures and the antitumor activities of tannins. Chem. Pharm. Bull. 35:1987;814-822.
26. Bhimani R.S., Troll W., Grunberger D., Frenkel K. Inhibition of oxidative stress in HeLa cells by chemopreventive agents. Cancer Res. 53:1993;4528-4533.
27. Pan M.H., Lin J.H., Lin-Shiau S.Y., Lin J.K. Induction of apoptosis by penta-O-galloyl-beta-D-glucose through activation of caspase-3 in human leukemia HL-60 cells. Eur. J. Pharmacol. 381:1999;171-183.